Related references
Note: Only part of the references are listed.Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain
Egilius L. H. Spierings et al.
PAIN PRACTICE (2016)
Chemotherapy-driven dysbiosis in the intestinal microbiome
E. Montassier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
M. Mazen Jamal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects
Khanh Bui et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Definitions and Outcome Measures of Clinical Trials Regarding Opioid-induced Constipation A Systematic Review
Jan Gaertner et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects
Mark Sanders et al.
PAIN MEDICINE (2015)
Practical Methods to Assess Chronic Constipation
Kyung Ho Song
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Prokinetics in the Management of Functional Gastrointestinal Disorders
Eamonn M. M. Quigley
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2015)
Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities
Alfred D. Nelson et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
A. Shin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials
L. Chang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials
Eirini Dimidi et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome
Emanuel Raschi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
The Effects of Mild or Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Naloxegol
Khanh Bui et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation
M. Camilleri et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
ACUTE REFRACTORY INTESTINAL PSEUDO-OBSTRUCTION IN MELAS: EFFICACY OF PRUCALOPRIDE
Guido Primiano et al.
NEUROLOGY (2014)
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
William D. Chey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
Byron Cryer et al.
PAIN MEDICINE (2014)
Elobixibat and its potential role in chronic idiopathic constipation
Andres Acosta et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2014)
Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation - a comparison in a controlled environment
R. Cinca et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Association of Low Dietary Intake of Fiber and Liquids With Constipation: Evidence From the National Health and Nutrition Examination Survey
Alayne D. Markland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
De novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes
Hitoshi Maruyama et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl- Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl- Currents
John Cuppoletti et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Evaluation of the Effect of Naloxegol on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT/QTc Study in Healthy Volunteers
Christer Gottfridsson et al.
CLINICAL THERAPEUTICS (2013)
Lubiprostone Decreases Mouse Colonic Inner Mucus Layer Thickness and Alters Intestinal Microbiota
Mark W. Musch et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Prucalopride: A Review of Its Use in the Management of Chronic Constipation
Gillian M. Keating
DRUGS (2013)
American Gastroenterological Association Technical Review on Constipation
Adil E. Bharucha et al.
GASTROENTEROLOGY (2013)
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist
Pamela R. Tsuruda et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation
Lynn Webster et al.
PAIN (2013)
Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults
Scott S. Malinowski et al.
PHARMACOTHERAPY (2013)
Probiotic supplementation decreases intestinal transit time: Meta-analysis of randomized controlled trials
Larry E. Miller et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis
Jan Tack et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation
Maura Corsetti et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome
Ruchit Sood et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2013)
Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Robert W. Busby et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
W. D. Chey et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
A Prospective Randomized Trial of Mosapride vs. Placebo in Constipation-Predominant Irritable Bowel Syndrome
Nabil M. Mansour et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation
Sara Nullens et al.
GUT (2012)
Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study
M. Simren et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
Michael Camilleri
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation
Banny S. Wong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Lubiprostone Activates Cl- Secretion via cAMP Signaling and Increases Membrane CFTR in the Human Colon Carcinoma Cell Line, T84
Mei Ao et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Lubiprostone for the Treatment of Adults with Constipation and Irritable Bowel Syndrome
Ron Schey et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey
Shawn X. Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Lubiprostone for the treatment of opioid-induced bowel dysfunction
Banny S. Wong et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Stimulant Laxatives for the Treatment of Chronic Constipation: Is it Time to Change the Paradigm?
Darren M. Brenner
GASTROENTEROLOGY (2011)
A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-lnduced Bowel Dysfunction in Patients With Non-Cancer Pain
Jan-Peter Jansen et al.
JOURNAL OF PAIN (2011)
A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-lnduced Bowel Dysfunction in Patients With Non-Cancer Pain
Gordon Irving et al.
JOURNAL OF PAIN (2011)
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Patients With Chronic, Nonmalignant Pain: A Randomized Controlled Study
Edward Michna et al.
JOURNAL OF PAIN (2011)
Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials
Neal E. Slatkin et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)
Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome
W. E. Whitehead et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Laxatives or methylnaltrexone for the management of constipation in palliative care patients
Bridget Candy et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
The influence of citalopram on interdigestive gastrointestinal motility in man
P. Janssen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study
M. Goldberg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation
Cornelius E. J. Sloots et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Laparoscopic assisted radical vaginal hysterectomy for cervical carcinoma: Morbidity and long-term follow-up
G. Mehra et al.
EJSO (2010)
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
Robert Buynak et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
Archana S. Rao et al.
GASTROENTEROLOGY (2010)
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial
O. Loewenstein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Prucalopride: a new drug for the treatment of chronic constipation
Jan Tack
Expert Review of Gastroenterology & Hepatology (2009)
Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome? Reply
H. Vahedi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon
A. K. Bassil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Modulation of the maturing gut barrier and microbiota:: A novel target in allergic disease
E. Isolauri et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature
Davide Tassinari et al.
JOURNAL OF PALLIATIVE MEDICINE (2008)
A placebo-controlled trial of prucalopride for severe chronic constipation
Michael Camilleri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
Lynn Webster et al.
PAIN (2008)
The narcotic bowel syndrome: Clinical features, pathophysiology, and management
David M. S. Grunkemeier et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Christel Rousseaux et al.
NATURE MEDICINE (2007)
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome
J. Tack et al.
GUT (2006)
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers
M Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
IL Khalif et al.
DIGESTIVE AND LIVER DISEASE (2005)
The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study
H Vahedi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients
Z Liu et al.
MOVEMENT DISORDERS (2005)
Alvimopan:: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction -: A 21-day treatment-randomized clinical trial
DM Paulson et al.
JOURNAL OF PAIN (2005)
Tegaserod-induced myocardial infarction: Case report and hypothesis
AJ Busti et al.
PHARMACOTHERAPY (2004)
Regulation of bile acid synthesis under reconstructed enterohepatic circulation in rats
M Nagano et al.
STEROIDS (2004)
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
E Kalso et al.
PAIN (2004)
Current concepts: Chronic constipation
A Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice
PA Dawson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury
K Krogh et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
Share Paper
